Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday.

The dividend yield investors could receive from Pfizer stock has risen from about 3% in early 2022 to 7% when the market closed on Aug. 5, 2025. Reliable dividend-paying stocks like Pfizer generally don't offer yields this high unless there's a reason to be concerned about the underlying business.

Chief Executive Albert Bourla says he is hopeful about finding a solution in response to Trump’s demand for price cuts.